cubeCONSENT 3.0 - For Subjects 对比 Rave eConsent 的使用情况和统计数据

'cubeCONSENT 3.0® - For Subjects' is a mobile app to access the subject portal for CRScube's eConsent solution 'cubeCONSENT 3.0®'. App Features: - Easy mobile phone access to clinical trial consent forms. - Quick and secure eSignatures. - Unlimited downloads of signed consent forms. CRScube: CRScube provides a comprehensive suite of eClinical solutions to CROs, Biotech, Pharmaceutical, Academic, and Non-Profit organizations globally. We are dedicated to providing the latest eClinical technology that is fast, flexible, and easy-to-use to streamline end-to-end operations for Phase I-IV, medical device, and Investigator-Initiated Trials.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

Medidata Patient Cloud Rave eConsent is our innovative, patient-friendly electronic informed consent and patient enrollment system for clinical trials. Potential participants gain full disclosure of the nature of the research and their involvement by viewing interactive tools and animations that better explain the risks and benefits of the trial. The app tracks metrics for adequate comprehension on the part of the participant and captures their voluntary choice to join the study with electronic signatures. Sites can streamline patient visits, track consents remotely, reduce on-site monitoring, and reduce the risk of findings from regulatory audits by using Rave eConsent’s unique technology for secure communications and identity verification. Sponsors benefit from a consistent consent review across all sites ensuring all required signatures are secured, manage consent amendments while reducing site and monitoring costs.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

cubeCONSENT 3.0 - For Subjects与Rave eConsent排名比较

对比 cubeCONSENT 3.0 - For Subjects 与 Rave eConsent 在过去 28 天内的排名趋势

排名

没有可用的数据

cubeCONSENT 3.0 - For Subjects 对比 Rave eConsent 的排名,按国家/地区比较

对比 cubeCONSENT 3.0 - For Subjects 与 Rave eConsent 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
cubeCONSENT 3.0 - For Subjects VS.
Rave eConsent

十二月 19, 2024